Widely used in the treatment of subependymal giant cell astrocytoma (SEGA) in patients with TSC, including children <2 years of age, mTOR inhibitors have been shown to be beneficial for tumor control and also seizure control in this patient population (24–26). This evidence concerns the gene MTOR and tuberous sclerosis.